- Home
- FGEN vs FMY Comparison
FGEN vs FMY Comparison
Compare FGEN & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- FMY
- Stock Information
- Founded
- FGEN 1993
- FMY 2005
- Country
- FGEN United States
- FMY United States
- Employees
- FGEN N/A
- FMY N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- FMY Finance/Investors Services
- Sector
- FGEN Health Care
- FMY Finance
- Exchange
- FGEN Nasdaq
- FMY Nasdaq
- Market Cap
- FGEN 45.1M
- FMY 51.0M
- IPO Year
- FGEN 2014
- FMY N/A
- Fundamental
- Price
- FGEN $8.66
- FMY $12.11
- Analyst Decision
- FGEN Strong Buy
- FMY
- Analyst Count
- FGEN 2
- FMY 0
- Target Price
- FGEN $146.50
- FMY N/A
- AVG Volume (30 Days)
- FGEN 31.2K
- FMY 10.1K
- Earning Date
- FGEN 11-10-2025
- FMY 01-01-0001
- Dividend Yield
- FGEN N/A
- FMY 6.98%
- EPS Growth
- FGEN N/A
- FMY N/A
- EPS
- FGEN 53.38
- FMY N/A
- Revenue
- FGEN $8,298,000.00
- FMY N/A
- Revenue This Year
- FGEN N/A
- FMY N/A
- Revenue Next Year
- FGEN N/A
- FMY N/A
- P/E Ratio
- FGEN $0.16
- FMY N/A
- Revenue Growth
- FGEN N/A
- FMY N/A
- 52 Week Low
- FGEN $4.85
- FMY $10.71
- 52 Week High
- FGEN $21.94
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- FGEN 25.08
- FMY 51.44
- Support Level
- FGEN $8.30
- FMY $12.04
- Resistance Level
- FGEN $11.39
- FMY $12.14
- Average True Range (ATR)
- FGEN 0.51
- FMY 0.11
- MACD
- FGEN -0.26
- FMY 0.01
- Stochastic Oscillator
- FGEN 12.95
- FMY 79.39
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.